about
Serologic reactivity to the emerging pathogen Granulibacter bethesdensisResidual NADPH oxidase and survival in chronic granulomatous diseaseGenes differentially expressed in conidia and hyphae of Aspergillus fumigatus upon exposure to human neutrophilsAntisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.HIF-1alpha: a master regulator of innate host defenses?Host defense functions of proteolytically processed and parent (unprocessed) cathelicidins of rabbit granulocytes.Hypomorphic Rag mutations can cause destructive midline granulomatous disease.Recurrent Granulibacter bethesdensis infections and chronic granulomatous disease.Tryptophan/kynurenine metabolism in human leukocytes is independent of superoxide and is fully maintained in chronic granulomatous disease.Simultaneous Host-Pathogen Transcriptome Analysis during Granulibacter bethesdensis Infection of Neutrophils from Healthy Subjects and Patients with Chronic Granulomatous DiseaseAssessment of atherosclerosis in chronic granulomatous diseaseChronic granulomatous disease: overview and hematopoietic stem cell transplantationAn AAVS1-targeted minigene platform for correction of iPSCs from all five types of chronic granulomatous disease.Innate immunity against Granulibacter bethesdensis, an emerging gram-negative bacterial pathogenRole of laeA in the Regulation of alb1, gliP, Conidial Morphology, and Virulence in Aspergillus fumigatus.Isolation and Functional Analysis of Human NeutrophilsCritical role of the complement system in group B streptococcus-induced tumor necrosis factor alpha release.Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous diseasePersistence of the bacterial pathogen Granulibacter bethesdensis in chronic granulomatous disease monocytes and macrophages lacking a functional NADPH oxidase.B-cell activating factor (BAFF) is elevated in chronic granulomatous disease.Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus.Short stature in partially corrected X-linked severe combined immunodeficiency--suboptimal response to growth hormone.Thoracic Surgery in Chronic Granulomatous Disease: a 25-Year Single-Institution Experience.Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.Early Intracellular Trafficking of Granulibacter bethesdensis in Human Macrophages.CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease.Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiencyRegulation of interactions of endotoxin with host cells.Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNATNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome
P50
Q24610283-D42F7E9A-F44A-45F4-92AD-530C0F3772BDQ28301969-1BCF0895-860C-4249-835E-752AE77D6B40Q33354129-63739F55-310B-40D9-AA36-6BA26B693002Q33857479-A7D6248A-88A2-40F7-AB25-AC0D2CF485BFQ33865949-82A62105-2784-4343-8BE8-09DA73D5E4ACQ34117610-38C6407A-B585-4341-8A40-D84BD4899BF0Q34122665-3B32450C-6B1C-4FF2-8A1A-E7A28114B27FQ34132929-0A30ED1F-33B8-4C7B-B610-D5587F337837Q34163016-73B77384-CF95-4C40-B94D-73870CAB5917Q34489893-7B63787D-3AC6-49B7-926B-D88B55D963D5Q34650014-F84C2E10-ABBF-4DDC-9DCE-CFB739D86D03Q35098193-B451394D-C1F2-40CF-BCBF-2C630E848519Q35591440-17EF04D5-6FBB-4A53-8EF3-5949B96EDE56Q35805503-83E67C0B-98C7-4F34-B819-8C730A4EBFBBQ36095285-A7EF928B-E12B-4045-A7FD-43C5CE609A56Q36344578-1A83BDC7-2FFC-42F4-A466-4BDC923AC397Q36375663-39A93490-50A6-4D3F-94B7-C70E0AF6AEDDQ36777548-5A01BAB0-9A22-4B7B-B686-13D2CA9CB336Q37161242-DD4F4865-E7B9-4BBF-B75D-82C5F6C67542Q37174792-715BBDA6-CDF0-4BAF-83AB-9006AB37AF9CQ37204164-1ECF8939-13C7-4AD1-ABDE-A5471D909A3AQ37273770-F2EDAD6A-3560-42B1-9C76-94EC8C0A0A36Q38920756-D743E2A7-E791-4A5B-902A-18CE607512DBQ39835313-921CAE5D-2578-4591-B142-E37362BB9D96Q40287252-C67B1CA1-7B7E-470C-8826-C759A226C01BQ40375767-F0E83594-C279-4AFA-B341-6CC69DC6AA87Q40480653-83F0CFC0-9AC9-4AAE-A275-BFC370D8ACD3Q40597635-92FD6253-ED89-4836-BDC8-FDA0BBD412CBQ43845859-D60FC82F-6CF0-420C-96E1-45963A9672CBQ75197384-A9410DA9-29F4-400C-8AA4-DA8BD5ECD9DEQ90411001-0C27B5E8-D38D-4598-9308-20078A7B5963
P50
description
researcher ORCID ID = 0000-0002-9624-7096
@en
wetenschapper
@nl
name
Kol A Zarember
@ast
Kol A Zarember
@en
Kol A Zarember
@es
Kol A Zarember
@nl
type
label
Kol A Zarember
@ast
Kol A Zarember
@en
Kol A Zarember
@es
Kol A Zarember
@nl
prefLabel
Kol A Zarember
@ast
Kol A Zarember
@en
Kol A Zarember
@es
Kol A Zarember
@nl
P106
P1153
6602399775
P31
P496
0000-0002-9624-7096